U2Bio - About the company
U2Bio is an unfunded company based in Seoul (South Korea), founded in 2009. It operates as a Developer of laboratory management tool for providers. U2Bio has not raised any funding yet. The company has 1241 active competitors, including 104 funded and 79 that have exited. Its top competitors include companies like Electronic Care Corp, Huma and Siemens Healthineers.
Key Metrics
Founded Year
2009
Location
Seoul, South Korea
Stage
Unfunded
Ranked
666th among 1241 active competitors
Employee Count
18 as on Jul 31, 2026
Similar Companies
Sign up to download U2Bio's company profile
U2Bio's funding and investors
U2Bio has not raised any funding rounds yet.
U2Bio's founders and board of directors
Founder? Claim ProfileU2Bio's employee count trend
U2Bio has 18 employees as of Jul 26. Here is U2Bio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
U2Bio's Competitors and alternates
Top competitors of U2Bio include Electronic Care Corp, Huma and Siemens Healthineers. Here is the list of Top 10 competitors of U2Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Electronic Care Corp 1999, United States, Acquired | Cloud-based administrative suite solutions for healthcare providers | $159M | 76/100 | |
2nd | Huma 2011, London (United Kingdom), Series D | Developer of regulated software platforms for digital health care workflows | $355M | 76/100 | |
3rd | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
4th | Confido Health 2022, Jersey City (United States), Series A | AI agents for healthcare administrative task automation and support | $13.2M | 66/100 | |
5th | MedeAnalytics 1994, Richardson (United States), Acquired | Healthcare data analytics and AI solutions for improved patient care | $57M | 65/100 | |
6th | hc1.com 2011, Indianapolis (United States), Series B | Transforming labs into strategic assets with actionable data and healthcare solutions | $52.1M | 64/100 | |
7th | Artera 2015, Santa Barbara (United States), Series D | Provider of a patient communication platform for healthcare organizations | $110M | 63/100 | |
8th | Synthpop 2023, Cambridge (United States), Series A | AI-powered clinical management software | $25.8M | 63/100 | |
9th | Infinitus 2019, San Francisco (United States), Series C | Developer of AI agents for automating healthcare-related phone calls and tasks | $103M | 63/100 | |
10th | HealthTrust 1999, Nashville (United States), Unfunded | Digital administrative tasks management tool for providers | - | - | 61/100 |
666th | U2Bio 2009, Seoul (South Korea), Unfunded | Developer of laboratory management tool for providers | - | - | 23/100 |
Looking for more details on U2Bio's competitors? Click here to see the top ones
U2Bio's Investments and acquisitions
U2Bio has made no investments or acquisitions yet.
Reports related to U2Bio
Here is the latest report on U2Bio's sector:
News related to U2Bio
•
WiseAI, signed a contract to supply AI affiliated services with U2BIOVenture Square•Aug 25, 2023•WISE AI, U2Bio
Are you a Founder ?
FAQs about U2Bio
Explore our recently published companies
- ABS - ALTERNATIVE BMW - San Mateo based, 2007 founded, Unfunded company
- Nufoer - Las Rozas de Madrid based, 2011 founded, Unfunded company
- Artiste Space - Philippines based, Unfunded company
- KA - 2026 founded, Unfunded company
- Gulf Coast Auto Glass - Spring based, 1976 founded, Unfunded company
- Dharwad International Residential School - Dharwad based, Unfunded company